Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H28O3 |
Molecular Weight | 316.4345 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4CC[C@@]23[H]
InChI
InChIKey=GTFUITFQDGVJSK-XGXHKTLJSA-N
InChI=1S/C20H28O3/c1-12(21)20(23)10-8-18-17-5-3-13-11-14(22)4-6-15(13)16(17)7-9-19(18,20)2/h11,15-18,23H,3-10H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1
Molecular Formula | C20H28O3 |
Molecular Weight | 316.4345 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/4117437Curator's Comment: description was created based on several sources, including, http://www.medicamentos.com.mx/DocHTM/22255.htm
Sources: http://www.ncbi.nlm.nih.gov/pubmed/4117437
Curator's Comment: description was created based on several sources, including, http://www.medicamentos.com.mx/DocHTM/22255.htm
Gestonorone is a progesterone analogue indicated for the treatment of benign prostatic hyperplasia and endometrial cancer. The drug is approved in many countries and used under the names Primostat and Depostat.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | PRIMOSTAT Approved UseConservative treatment of benign prostatic hyperplasia and palliative treatment of severe endometrial cancer. |
|||
Palliative | PRIMOSTAT Approved UseConservative treatment of benign prostatic hyperplasia and palliative treatment of severe endometrial cancer. |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.medicamentos.com.mx/DocHTM/22255.htm
Slow intramuscular injection of 200 mg every week for 2 to 3 months.
Route of Administration:
Intramuscular
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:57:18 GMT 2023
by
admin
on
Fri Dec 15 17:57:18 GMT 2023
|
Record UNII |
H4G605B7VP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
L02AB03
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
||
|
WHO-VATC |
QL02AB03
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
||
|
WHO-ATC |
G03DA01
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
||
|
WHO-VATC |
QG03DA01
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4563
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
PRIMARY | |||
|
218-378-2
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
PRIMARY | |||
|
H4G605B7VP
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
PRIMARY | |||
|
GESTONORONE
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
PRIMARY | |||
|
4793
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB13230
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
PRIMARY | |||
|
DTXSID50175631
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
PRIMARY | |||
|
102210
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
PRIMARY | |||
|
2137-18-0
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL3707212
Created by
admin on Fri Dec 15 17:57:18 GMT 2023 , Edited by admin on Fri Dec 15 17:57:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |